WASHINGTON - Federal regulators Thursday ordered reviews of dozens of ongoing patient studies of the prescription painkillers Celebrex and Bextra in light of findings that both drugs may increase the ...

NEW YORK (Reuters) - Ads for Pfizer Inc.'s Celebrex arthritis drug are set to splash across U.S. television screens on Monday after more than a two-year hiatus, with an unusual upfront focus on its ...

We collaborate with the world's leading lawyers to deliver news tailored for you. Sign Up for any (or all) of our 25+ Newsletters. Some states have laws and ethical rules regarding solicitation and ...

Painful surgical adhesions may be preventable by taking the COX-2 inhibitor Celebrex®, a common oral arthritis drug, just before and immediately after surgery, report researchers at Children's ...

April 7, 2005 — -- The Food and Drug Administration asked Pfizer Inc. to pull the painkiller Bextra off the shelves today in a voluntary recall after considering data that the drug poses ...

SALT LAKE CITY -- Pfizer has settled a lawsuit filed by Brigham Young University over development of the blockbuster painkiller Celebrex for $450 million. Terms of the settlement weren't disclosed in ...

Embed <iframe src="https://www.npr.org/player/embed/4236841/4236842" width="100%" height="290" frameborder="0" scrolling="no" title="NPR embedded audio player"> NPR's ...

It’s been a painful 15 months both for people with arthritis and for the companies that make their painkilling drugs. The once high-flying anti-inflammatories known as cox-2 inhibitors nearly crashed ...

The maker of the best-selling arthritis drug Celebrex will not be allowed to claim that its product is safer for the stomach and digestive tract than older, less expensive arthritis medicines, the ...

(Reuters) - Pfizer Inc has agreed to pay $164 million to settle a shareholder class action accusing the drug maker of misrepresenting the clinical trial results for Celebrex. The settlement was ...